EVI1 and hematopoietic disorders: History and perspectives

Gene

Volumn 368, Issue 1-2, 2006, Pages 1-11

  Nucifora, Giuseppina ^a   Laricchia Robbio, Leopoldo ^a   Senyuk, Vitalyi ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Ecotropic retrovirus; EVI1 (ecotropic viral integration site 1); Human leukemia; Murine myeloid leukemia

Indexed keywords

ALPHA INTERFERON; ARSENIC TRIOXIDE; CYTOKINE; ECOTROPIC VIRAL INTEGRATION SITE; GENE PRODUCT; HYBRID PROTEIN; MYELODYSPLASIA SYNDROME 1 ECOTROPIC VIRAL INTEGRATION SITE FUSION PROTEIN; ONCOPROTEIN; SMAD3 PROTEIN; THALIDOMIDE; TRANSCRIPTION FACTOR RUNX1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; BIOCHEMISTRY; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHROMOSOME ABERRATION; ECOTROPIC VIRUS; GENE IDENTIFICATION; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC DISORDER; HUMAN; HYPERPLASIA; LEUKEMIA; LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CELL TRANSFORMATION; VIRUS DNA CELL DNA INTERACTION; ZINC FINGER MOTIF;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HEMATOLOGIC DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; PHYLOGENY; PROTO-ONCOGENES; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

MURINAE;

EID: 33344474674     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.09.020     Document Type: Review

References (71)

1. H. Asou Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene Jpn. J. Cancer Res. 87 1996 269 274
2. S. Barjesteh van Waalwijk van Doorn-Khosrovani High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients Blood 101 2003 837 845
3. S. Barjesteh van Waalwijk van Doorn-Khosrovani, C. Erpelinck, B. Lowenberg, and R. Delwel Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia Exp. Hematol. 31 2003 1066 1072
4. C. Bartholomew, A. Kilbey, A.M. Clark, and M. Walker The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation Oncogene 14 1997 569 577
5. D. Bordereaux, S. Fichelson, P. Tambourin, and S. Gisselbrecht Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs Oncogene 5 1990 925 927
6. S. Buonamici EVI1 induces myelodysplastic syndrome in mice J. Clin. Invest. 114 2004 713 719
7. S. Buonamici EVI1 abrogates interferon-alpha response by selectively blocking PML induction J. Biol. Chem. 280 2005 428 436
8. B. Calmels Recurrent retroviral vector integration at the MDS1-EVI1 locus in non-human primate hematopoietic cells Blood 2005 (Jun 2, Electronic publication ahead of print)
9. S. Chakraborty, V. Senyuk, S. Sitailo, Y. Chi, and G. Nucifora Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles J. Biol. Chem. 276 2001 44936 44943
10. Y. Chi, V. Senyuk, S. Chakraborty, and G. Nucifora EVI1 promotes cell proliferation by interacting with BRG1 and blocking the repression of BRG1 on E2F1 activity J. Biol. Chem. 278 2003 49806 49811
11. G.M. Cuenco, and R. Ren Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice Oncogene 23 2004 569 579
12. G.M. Cuenco, G. Nucifora, and R. Ren Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML Proc. Natl. Acad. Sci. U. S. A. 97 2000 1760 1765
13. M. de Bruijn, and N.A. Speck Core-binding factors in hematopoiesis and immune function Oncogene 23 2004 4238 4248
14. R. Delwel, T. Funabiki, B.L. Kreider, K. Morishita, and J.N. Ihle Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA Mol. Cell. Biol. 13 1993 4291 4300
15. S. Fears, C. Mathieu, N. Zeleznik-Le, S. Huang, J.D. Rowley, and G. Nucifora Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family Proc. Natl. Acad. Sci. U. S. A. 93 1996 1642 1647
16. T. Funabiki, B.L. Kreider, and J.N. Ihle The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG Oncogene 9 1994 1575 1581
17. G. Garriga, C. Guenther, and H.R. Horvitz Migrations of the Caenorhabditis elegans HSNs are regulated by egl-43, a gene encoding two zinc finger proteins Genes Dev. 7 1993 2097 2109
18. D. Helbling The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin Proc. Natl. Acad. Sci. U. S. A. 101 2004 13312 13317
19. P.R. Hoyt The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development Mech. Dev. 65 1997 55 70
20. S. Huang, G. Shao, and L. Liu The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression J. Biol. Chem. 273 1998 15933 15939
21. K. Izutsu, M. Kurokawa, Y. Imai, K. Maki, K. Mitani, and H. Hirai The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling Blood 97 2001 2815 2822
22. K. Izutsu The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP Oncogene 21 2002 2695 2703
23. T. Jenuwein, G. Laible, R. Dorn, and G. Reuter SET domain proteins modulate chromatin domains in eu- and heterochromatin Cell. Mol. Life Sci. 54 1998 80 93
24. G.L. Jiang, and S. Huang The yin-yang of PR-domain family genes in tumorigenesis Histol. Histopathol. 15 2000 109 117
25. B. Johansson, T. Fioretos, and F. Mitelman Cytogenetic and molecular genetic evolution of chronic myeloid leukemia Acta Haematol. 107 2002 76 94
26. B.L. Kreider, S.H. Orkin, and J.N. Ihle Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene Proc. Natl. Acad. Sci. U. S. A. 90 1993 6454 6458
27. M. Kurokawa The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence Oncogene 11 1995 833 840
28. M. Kurokawa The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3 Nature 394 1998 92 96
29. M. Kurokawa The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death EMBO J. 19 2000 2958 2968
30. O. Kustikova Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking Science 308 2005 1171 1174
31. Y.L. Kwong Translocation (2;3) and myeloid disorders Cancer Genet. Cytogenet. 90 1996 93
32. S.E. Langabeer MRC Adult Leukaemia Working Party. EVI1 expression in acute myeloid leukaemia Br. J. Haematol. 112 2001 208 211
33. D. Levanon, and Y. Groner Structure and regulated expression of mammalian RUNX genes Oncogene 23 2004 4211 4219
34. Y. Lin, K. Wong, and K. Calame Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation Science 276 1997 569 596
35. L. Liu, G. Shao, G. Steele-Perkins, and S. Huang The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter J. Biol. Chem. 272 1997 2984 2991
36. D. Louz Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice Leukemia 14 2000 1876 1884
37. K. Maki Dysplastic definitive hematopoiesis in AML1/Evi-1 knock-in embryos Blood 2005 (May 24, Electronic publication ahead of print)
38. R. Marmorstein Structure of SET domain proteins: a new twist on histone methylation Trends Biochem. Sci. 28 2003 59 62
39. N. Mochizuki A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)- positive leukemia cells Blood 96 2000 3209 3214
40. K. Morishita, E. Parganas, E.C. Douglass, and J.N. Ihle Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts Oncogene 5 1990 963 971
41. K. Morishita, E. Parganas, T. Matsugi, and J.N. Ihle Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor Mol. Cell. Biol. 12 1992 183 189
42. M.L. Mucenski Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors Mol. Cell. Biol. 8 1988 301 308
43. F. Mugneret, E. Solary, B. Favre, D. Caillot, I. Sidaner, and H. Guy New case of t(3;17)(q26;q22) as an additional change in a Philadelphia-positive chronic myelogenous leukemia in acceleration Cancer Genet. Cytogenet. 60 1992 90 92
44. G. Nucifora, C.R. Begy, P. Erickson, H.A. Drabkin, and J.D. Rowley The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1 Proc. Natl. Acad. Sci. U. S. A. 90 1993 7784 7788
45. G. Nucifora Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis Blood 81 1993 2728 2734
46. G. Nucifora Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations Proc. Natl. Acad. Sci. U. S. A. 91 1994 4004 4008
47. S. Palmer Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins J. Biol. Chem. 276 2001 25834 25840
48. P. Peeters Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders Cancer Res. 57 1997 564 569
49. A.S. Perkins, J.A. Mercer, N.A. Jenkins, and N.G. Copeland Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development Development 111 1991 479 487
50. A. Raza Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression Leuk. Res. 28 2004 791 803
51. C.M. Rubin t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia Blood 76 1990 2594 2598
52. I. Sakai Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22) Genes Chromosomes Cancer 2005 (Electronic publication ahead of print)
53. U. Schaeper, J.M. Boyd, S. Verma, E. Uhlmann, T. Subramanian, and G. Chinnadurai Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation Proc. Natl. Acad. Sci. U. S. A. 92 1995 10467 10471
54. R. Schneider, A.J. Bannister, and T. Kouzarides Unsafe SETs: histone lysine methyltransferases and cancer Trends Biochem. Sci. 27 2002 396 402
55. V. Senyuk, S. Chakraborty, F.M. Mikhail, R. Zhao, Y. Chi, and G. Nucifora The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells Oncogene 21 2002 3232 3240
56. V. Senyuk, K.K. Sinha, S. Chakraborty, S. Buonamici, and G. Nucifora P/CAF and GCN5 acetylate the AML1/MDS1/EVI1 fusion oncoprotein Biochem Biophys. Res. Commun. 307 2003 980 986
57. V. Senyuk, D. Li, A. Zakharov, F. Mikhail, and G. Nucifora The distal Zn-finger domain of AME is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro Cancer Res. 65 17 2005 7603 7611
58. S. Sitailo, R. Sood, K. Barton, and G. Nucifora Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements Leukemia 13 1999 1639 1645
59. J. Soderholm, H. Kobayashi, C. Mathieu, J.D. Rowley, and G. Nucifora The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator Leukemia 11 1997 352 358
60. R. Sood, A. Talwar-Trikha, S.R. Chakrabarti, and G. Nucifora MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1 Leukemia 13 1999 348 357
61. C.T. Storlazzi A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 Ann. Hematol. 83 2004 78 83
62. K. Suzukawa Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26) Blood 84 1994 2681 2688
63. T. Tanaka, J. Nishida, K. Mitani, S. Ogawa, Y. Yazaki, and H. Hirai Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain J. Biol. Chem. 269 1994 24020 24026
64. T. Tanaka Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias Mol. Cell. Biol. 15 1995 2383 2392
65. N. Testoni 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features Haematologica 84 1999 690 694
66. P.J. Valk Prognostically useful gene-expression profiles in acute myeloid leukemia N. Engl. J. Med. 350 2004 1617 1628
67. A.J. van Wijnen Nomenclature for Runt-related (RUNX) proteins Oncogene 23 2004 4209 4210
68. X.H. Yang, and S. Huang PFM1 (PRDM4), a new member of the PR-domain family, maps to a tumor suppressor locus on human chromosome 12q23-q24.1 Genomics 61 1999 319 325
69. Y. Yufu Expression of EVI1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13-14) Am. J. Hematol. 53 1996 30 34
70. C.S. Zent The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties Proc. Natl. Acad. Sci. U. S. A. 93 1996 1044 1048
71. D. Zoccola, L. Legros, P. Cassuto, J.G. Fuzibet, G. Nucifora, and S.D. Raynaud A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement Leukemia 17 2003 643 645